- Homepage
- Economy and Business
- FDA rejects psychedelic drug MDMA as a treatment for PTSD
FDA rejects psychedelic drug MDMA as a treatment for PTSD
3 months ago
11
Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data submitted to date,” and requested an additional late-stage study. Read More
Related
Kamala Harris vows not to interfere with the Fed—unlike Trum...
3 months ago
17
Even an uptick in inflation is unlikely to spoil a Fed rate ...
3 months ago
12
Argentina’s economic shock therapy and fintech boom are wipi...
3 months ago
11
Donald Trump’s campaign says its emails were hacked and poin...
3 months ago
11
See what Google’s original office looked like when it starte...
3 months ago
10
Zum founder Ritu Narayan explains why she wants to disrupt s...
3 months ago
12
Mexican drug lord 'El Mayo' Zambada says he was ambushed, ki...
3 months ago
11
Susan Wojcicki on how she built YouTube as the new TV
3 months ago
7
Nashville man accused of helping thousands of North Koreans ...
3 months ago
10
Former YouTube CEO Susan Wojcicki has died at 56
3 months ago
11
‘SuperAgers’ have optimal brains well into their 80s. Can yo...
3 months ago
12
© REPORTER 24 NEWS 2024. All rights are reserved